Rivastigmine Film, Extended Release — FDA Drug Shortage

To Be Discontinued — Mylan Pharmaceuticals Inc., A Viatris Company

The FDA lists a drug shortage record for Rivastigmine Film, Extended Release (film, extended release) from Mylan Pharmaceuticals Inc., A Viatris Company with status To Be Discontinued. The shortage was first posted on Sep 18, 2026.

Shortage details

Status
To Be Discontinued
Company
Mylan Pharmaceuticals Inc., A Viatris Company
Package NDC
0378-9070-93
Dosage Form
Film, Extended Release
Presentation
Rivastigmine, Film, Extended Release, 4.6 mg/24 h (NDC 0378-9070-93)
Initial Posting
Sep 18, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.